1-12 of 12
Rafael Madero-Marroquin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in progress – a phase 1b trial of ivosidenib combined with ruxolitinib in IDH1-mutated advanced myeloproliferative neoplasms

Free
Anand Patel, Theodore Karrison, Emily Dworkin, Rafael Madero-Marroquin, Austin Wesevich, Gregory Roloff, Caner Saygin, Mariam Nawas, Michael Drazer, Adam Duvall, Satyajit Kosuri, Michael Thirman, Wendy Stock, Richard Larson, Olatoyosi Odenike
Journal: Blood
Blood (2025) 146 (Supplement 1): 5608.
https://doi.org/10.1182/blood-2025-5608
Published: 2025
Journal Articles

Spiritual wellness and quality-of-life in adult patients with newly diagnosed acute leukemia receiving initial therapy: Patient-reported outcomes (PROs) from a prospective observational study

Free
Hannah Johnston, Abigail Sneider, Tuula Pera, Rafael Madero-Marroquin, Austin Wesevich, Gregory Roloff, Mariam Nawas, Anand Patel, Michael Drazer, Adam Duvall, Satyajit Kosuri, Michael Thirman, Olatoyosi Odenike, Richard Larson, Caner Saygin, Wendy Stock, Christopher Daugherty
Journal: Blood
Blood (2025) 146 (Supplement 1): 6382.
https://doi.org/10.1182/blood-2025-6382
Published: 2025
Journal Articles

Clinical and molecular characteristics of Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia with central nervous system relapse versus systemic relapse: Results from consortium on myeloid malignancies and neoplastic diseases (COMMAND)

Free
Rafael Madero-Marroquin, Ravi Kishore Narra, Alice Mims, Alexander Coltoff, Georgio Medawar, Brooke Hisrich, Rory Shallis, Cameron Hunter, Vamsi Kota, Tamer Othman, Brian Jonas, Shreya Desai, Guilherme Sacchi De Camargo Correia, Adam Duvall, Neil Palmisiano, Emily Curran, Zulfa Omer, Anjali Advani, Ehab Atallah, Mark Litzow, Anand Patel, Talha Badar
Journal: Blood
Blood (2025) 146 (Supplement 1): 3320.
https://doi.org/10.1182/blood-2025-3320
Published: 2025
Journal Articles

Prognostic risk integration for survival modeling (PRISM) in newly diagnosed acute myeloid leukemia treated with venetoclax:  a multinational retrospective cohort study

Free
Curtis Lachowiez, Andy Kaempf, Jad Othman, Seongseok Yun, Mael Heiblig, Michael Heuser, Rabia Shahswar, Anand Patel, Rafael Madero-Marroquin, Joseph Cannova, Irene Zacheo, Federica Monaco, Dimitrios Drekolias, Fatima Tuz Zahra, Amine Belhabri, Urbain Tauveron-Jalenques, Emmanuelle Tavernier, Martin Carre, Gaspar Aspas Requena, Nicola Long, Rachel Cook, Elie Traer, Ronan Swords, Jennifer Saultz, Jenny O'Nions, Faisal Basheer, John Laurie, Shivani Handa, Eytan Stein, Maria Baer, Wendy Stock, Rebecca Olin, William Blum, Gary Schiller, Tara Lin, Emily Curran, Ying Huang, Rina Welkie, Ashley Yocum, Giovanni Marconi, Ellen Madarang, Justin Watts, Yazan Madanat, Richard Dillon, Sanam Loghavi, Joshua Zeidner, Daniel Pollyea, Elsa Bernard
Journal: Blood
Blood (2025) 146 (Supplement 1): 453.
https://doi.org/10.1182/blood-2025-453
Published: 2025
Journal Articles

Primary efficacy analysis of phase II study investigating tyrosine kinase inhibitor (TKI) and inotuzumab ozogamicin-based therapy for newly diagnosed Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL)

Free
Anand Patel, Adam Duvall, Caner Saygin, Howard Weiner, Emily Dworkin, Afsheen Noorani, Jamie Mathews, Angela Lager, Sandeep Gurbuxani, Peng Wang, Rafael Madero-Marroquin, Austin Wesevich, Michael Drazer, Mariam Nawas, Gregory Roloff, Satyajit Kosuri, Michael Thirman, Richard Larson, Olatoyosi Odenike, Theodore Karrison, Wendy Stock
Journal: Blood
Blood (2025) 146 (Supplement 1): 441.
https://doi.org/10.1182/blood-2025-441
Published: 2025
Journal Articles

Outcomes following lower-intensity therapy with venetoclax in patients with NPM1-mutated Acute Myeloid Leukemia are highly dependent upon co-occurring mutations

Free
Curtis Lachowiez, Seongseok Yun, Mael Heiblig, Michael Heuser, Rabia Shahswar, Anand Patel, Rafael Madero-Marroquin, Joseph Cannova, Dimitrios Drekolias, Fatima Tuz Zahra, Amine Belhabri, Urbain Tauveron-Jalenques, Emmanuelle Tavernier, Martin Carre, Gaspar Aspas Requena, Jenny O'Nions, Faisal Basheer, John Laurie, Ellen Madarang, Richard Dillon, Sanam Loghavi, Joshua Zeidner, Dan Pollyea, Justin Watts, Jad Othman
Journal: Blood
Blood (2025) 146 (Supplement 1): 5278.
https://doi.org/10.1182/blood-2025-5278
Published: 2025
Journal Articles

Trial in progress: A Phase I/II study to investigate the combination of LP-118, ponatinib, vincristine and dexamethasone (LPVd regimen) in relapsed/refractory T-ALL/lbl

Free
Caner Saygin, Anand Patel, Hannah Levavi, Kristen O'Dwyer, Meixiao Long, Fernando Vargas Madueno, Chenyu Lin, Theodore Karrison, Howard Weiner, Adam Duvall, Satyajit Kosuri, Rafael Madero-Marroquin, Gregory Roloff, Michael Drazer, Michael Thirman, Richard Larson, Olatoyosi Odenike, L. Evan Reddick, Yu Chen, Stephen Anthony, Wendy Stock
Journal: Blood
Blood (2025) 146 (Supplement 1): 5136.
https://doi.org/10.1182/blood-2025-5136
Published: 2025
Journal Articles

Interim Results of a Phase II Study Investigating Dasatinib and Inotuzumab Ozogamicin-Based Induction for Newly-Diagnosed Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Free
Anand Ashwin Patel, Adam S. Duvall, Caner Saygin, Howard Weiner, Emily Dworkin, Afsheen Noorani, Jamie Matthews, Rafael Madero Marroquin, Michael W Drazer, Mariam T. Nawas, Gregory W Roloff, Satyajit Kosuri, Michael J. Thirman, Richard A. Larson, Olatoyosi Odenike, Theodore Karrison, Wendy Stock
Journal: Blood
Blood (2024) 144 (Supplement 1): 1432.
https://doi.org/10.1182/blood-2024-193442
Published: 2024
Journal Articles

Next-Generation Sequencing-Based T-Cell Receptor (TR) Measurable Residual Disease Monitoring Does Not Predict Relapse in T-Lineage Acute Lymphoblastic Leukemia

Free
Rafael Madero-Marroquin, Adnan Askari, Yenny Vanegas Moreno, Clare E Anderson, Talha Badar, Guru Subramanian Guru Murthy, Chenyu Lin, Alexander Coltoff, Adam S. Duvall, Richard A. Larson, Olatoyosi Odenike, Wendy Stock, Anand Ashwin Patel, Caner Saygin
Journal: Blood
Blood (2024) 144 (Supplement 1): 5937.
https://doi.org/10.1182/blood-2024-203665
Published: 2024
Journal Articles

Analysis of CD58 As a Predictive Marker of Morphologic Response to Inotuzumab Ozogamicin in Patients with B-Cell Acute Lymphoblastic Leukemia

Free
Rafael Madero-Marroquin, Ryan Hunter, Caner Saygin, Hannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, Wendy Stock, Sandeep Gurbuxani, Anand Ashwin Patel
Journal: Blood
Blood (2023) 142 (Supplement 1): 6071.
https://doi.org/10.1182/blood-2023-180883
Published: 2023
Journal Articles

Prognostic Significance of Hospitalization Status at Second Cycle of Hypomethylating Agent Induction Therapy in Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Free
Douglas Tremblay, MD, Rafael Madero-Marroquin, MD, Guido Lancman, MD, Alexander Coltoff, MD, Jonathan Feld, MD, Jessica Caro, MD, Nicole Zubizarreta, MPH, Marina Kremyanskaya, Alla Keyzner, MD, Michal Bar-Natan, MD, Shyamala C. Navada, MD, Lewis R. Silverman, Janice L. Gabrilove, MD, John Mascarenhas, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5102.
https://doi.org/10.1182/blood-2019-123288
Published: 2019
Journal Articles

Aberrant Hedgehog Signaling in Myelodysplastic Syndrome Accelerates Leukemic Transformation Via Smoothened-Dependent and Smoothened-Independent Gli1 Activation

Free
Bonnie W Lau, MD PhD, Kyounghee Huh, MS, Rafael Madero-Marroquin, MD, Federico De Marchi, MD, Yiting Lim, PhD, Francisco Lobo, PhD, Luigi Marchionni, PhD, Peter D. Aplan, MD, William Matsui, MD, Lukasz P. Gondek, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1676.
https://doi.org/10.1182/blood.V130.Suppl_1.1676.1676
Published: 2017